Skip to main content
. 2021 Dec 27;28(8):1680–1689. doi: 10.1158/1078-0432.CCR-21-3329

Figure 3.

Figure 3. AUROC curve by signature and tumor type estimated in the direction of the hypothesized association. The symbols are sized to represent the population sizes of the different cohorts that influence the AUROC curve estimates shown in Table 2. Non-TcellinfGEP consensus signatures were evaluated after detrending for TcellinfGEP. AUROC, area under the receiver operating characteristic; EMT, epithelial-to-mesenchymal transition; GEP, gene expression profile; gMDSC, granulocytic myeloid-derived suppressor cells; HNSCC, head and neck squamous cell carcinoma; mMDSC, monocytic myeloid-derived suppressor cells; RCC, renal cell carcinoma; TcellinfGEP, T-cell–inflamed gene expression profile; TGFβ, transforming growth factor β; TNBC, triple-negative breast cancer.

AUROC curve by signature and tumor type estimated in the direction of the hypothesized association. The symbols are sized to represent the population sizes of the different cohorts that influence the AUROC curve estimates shown in Table 2. Non-TcellinfGEP consensus signatures were evaluated after detrending for TcellinfGEP. AUROC, area under the receiver operating characteristic; EMT, epithelial-to-mesenchymal transition; GEP, gene expression profile; gMDSC, granulocytic myeloid-derived suppressor cells; HNSCC, head and neck squamous cell carcinoma; mMDSC, monocytic myeloid-derived suppressor cells; RCC, renal cell carcinoma; TcellinfGEP, T-cell–inflamed gene expression profile; TGFβ, transforming growth factor β; TNBC, triple-negative breast cancer.